Neurology

Bioimaging Techniques and Biomarkers, Biosimilars

Bioimaging, a subfield of biomedicine and bioengineering, is the development and use of imaging technologies and computer software tools in the production of pharmaceutical specimens. A biomarker is a biological molecule that may be identified in tissues, bodily fluids, or blood as a sign of a disorder, illness, or process, regardless of how ordinary or unusual it may be. A biomarker may be used to assess how the body reacts to an illness or condition's therapy. A brand-name biologic drug with prior approval has a structure that is similar to yet distinct from a biosimilar drug.

Magnetic resonance imaging (MRI), Subclinical manifestation, DNA sequence, Functional imaging, Ultrasound imaging, Clinical trails, Computed tomography, Positron emission tomography (PET), Bio imaging techniques.